Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Pelly VS"'
Autor:
Hanson AL; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Mulè MP; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; NIH-Oxford-Cambridge Scholars Program, Department of Medicine, University of Cambridge, Cambridge, UK., Ruffieux H; MRC Biostatistics Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Mescia F; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Bergamaschi L; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Pelly VS; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Turner L; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Kotagiri P; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Göttgens B; British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK., Hess C; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge, UK.; Department of Haematology, Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Gleadall N; Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.; Botnar Research Centre for Child Health (BRCCH), University of Basel and ETH Zurich, Basel, Switzerland., Bradley JR; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Nathan JA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Lyons PA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Drakesmith H; MRC Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK. smith.k@wehi.edu.au.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. smith.k@wehi.edu.au.; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. smith.k@wehi.edu.au.; University of Melbourne, Melbourne, Victoria, Australia. smith.k@wehi.edu.au.
Publikováno v:
Nature immunology [Nat Immunol] 2024 Mar; Vol. 25 (3), pp. 471-482. Date of Electronic Publication: 2024 Mar 01.
Autor:
Ruffieux H; MRC Biostatistics Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. helene.ruffieux@mrc-bsu.cam.ac.uk., Hanson AL; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Lodge S; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia., Lawler NG; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia., Whiley L; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Perron Institute for Neurological and Translational Science, Nedlands, Western Australia, Australia., Gray N; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia., Nolan TH; MRC Biostatistics Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Bergamaschi L; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Mescia F; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Turner L; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., de Sa A; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Pelly VS; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Kotagiri P; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Kingston N; Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.; NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge, UK., Bradley JR; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge, UK., Holmes E; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK., Wist J; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Chemistry Department, Universidad del Valle, Cali, Colombia., Nicholson JK; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Institute of Global Health Innovation, Imperial College London, London, UK., Lyons PA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Richardson S; MRC Biostatistics Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Bantug GR; Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.; Botnar Research Centre for Child Health (BRCCH) University Basel & ETH Zurich, Basel, Switzerland., Hess C; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK. ch818@cam.ac.uk.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. ch818@cam.ac.uk.; Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland. ch818@cam.ac.uk.; Botnar Research Centre for Child Health (BRCCH) University Basel & ETH Zurich, Basel, Switzerland. ch818@cam.ac.uk.
Publikováno v:
Nature immunology [Nat Immunol] 2023 Feb; Vol. 24 (2), pp. 349-358. Date of Electronic Publication: 2023 Jan 30.
Autor:
Bell CR; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK., Pelly VS; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK., Moeini A; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK., Chiang SC; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK., Flanagan E; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK., Bromley CP; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK., Clark C; Molecular Biology Core Facility, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK., Earnshaw CH; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK., Koufaki MA; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK., Bonavita E; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK., Zelenay S; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK. Santiago.Zelenay@cruk.manchester.ac.uk.; The Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, UK. Santiago.Zelenay@cruk.manchester.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2022 Apr 19; Vol. 13 (1), pp. 2063. Date of Electronic Publication: 2022 Apr 19.
Autor:
Pelly VS; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, United Kingdom., Moeini A; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, United Kingdom., Roelofsen LM; Divison of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Bonavita E; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, United Kingdom., Bell CR; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, United Kingdom., Hutton C; Systems Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, United Kingdom., Blanco-Gomez A; Systems Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, United Kingdom., Banyard A; Flow Cytometry, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, United Kingdom., Bromley CP; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, United Kingdom., Flanagan E; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, United Kingdom., Chiang SC; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, United Kingdom., Jørgensen C; Systems Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, United Kingdom., Schumacher TN; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands., Thommen DS; Divison of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Zelenay S; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, United Kingdom. Santiago.Zelenay@cruk.manchester.ac.uk.; The Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, United Kingdom.
Publikováno v:
Cancer discovery [Cancer Discov] 2021 Oct; Vol. 11 (10), pp. 2602-2619. Date of Electronic Publication: 2021 May 24.
Autor:
Bonavita E; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK., Bromley CP; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK., Jonsson G; Department of Life Sciences, Imperial College London, London, UK., Pelly VS; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK., Sahoo S; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK., Walwyn-Brown K; Manchester Collaborative Centre for Inflammation Research, The Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, UK., Mensurado S; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Moeini A; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK., Flanagan E; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK., Bell CR; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK., Chiang SC; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK., Chikkanna-Gowda CP; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK., Rogers N; The Francis Crick Institute, London, UK., Silva-Santos B; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Jaillon S; Humanitas University, Department of Biomedical Sciences, Humanitas Clinical and Research Center, IRCCS, Milan, Italy., Mantovani A; Humanitas University, Department of Biomedical Sciences, Humanitas Clinical and Research Center, IRCCS, Milan, Italy., Reis e Sousa C; The Francis Crick Institute, London, UK., Guerra N; Department of Life Sciences, Imperial College London, London, UK., Davis DM; Manchester Collaborative Centre for Inflammation Research, The Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, UK., Zelenay S; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK. Electronic address: santiago.zelenay@cruk.manchester.ac.uk.
Publikováno v:
Immunity [Immunity] 2020 Dec 15; Vol. 53 (6), pp. 1215-1229.e8. Date of Electronic Publication: 2020 Nov 20.
Autor:
Bonavita E; Cancer Inflammation and Immunity Group, CRUK Manchester Institute, The University of Manchester, Manchester, England, UK., Pelly VS; Cancer Inflammation and Immunity Group, CRUK Manchester Institute, The University of Manchester, Manchester, England, UK., Zelenay S; Cancer Inflammation and Immunity Group, CRUK Manchester Institute, The University of Manchester, Manchester, England, UK Santiago.Zelenay@cruk.manchester.ac.uk.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2018 Jan 02; Vol. 215 (1), pp. 9-11. Date of Electronic Publication: 2017 Dec 20.
Autor:
Entwistle LJ; Allergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Pelly VS; Allergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Coomes SM; Allergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Kannan Y; Allergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Perez-Lloret J; Allergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Czieso S; Allergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Silva Dos Santos M; Metabolomics, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., MacRae JI; Metabolomics, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Collinson L; Electron Microscopy, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Sesay A; Advanced Sequencing Facility, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Nikolov N; Advanced Sequencing Facility, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Metidji A; AhR Immunity Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Helmby H; Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Hui DY; Department of Pathology, Metabolic Disease Research Center, University of Cincinnati College of Medicine, Cincinnati, OH 45237, USA., Wilson MS; Allergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Immunology Discovery, Genentech Inc., South San Francisco, CA 94080, USA. Electronic address: wilson.mark@gene.com.
Publikováno v:
Cell host & microbe [Cell Host Microbe] 2017 Oct 11; Vol. 22 (4), pp. 484-493.e5.
Autor:
Kannan Y; Allergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, London, United Kingdom., Entwistle LJ; Allergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, London, United Kingdom., Pelly VS; Allergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, London, United Kingdom., Perez-Lloret J; Allergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, London, United Kingdom., Walker AW; Pathogen Genomics Group, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.; Microbiology Group, The Rowett Institute, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom., Ley SC; Immune Cell Signaling Laboratory, The Francis Crick Institute, United Kingdom., Wilson MS; Allergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, London, United Kingdom.; Immunology Discovery. Genentech Inc. South San Francisco, CA, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2017 Jul 31; Vol. 13 (7), pp. e1006536. Date of Electronic Publication: 2017 Jul 31 (Print Publication: 2017).
Autor:
Pelly VS; Allergy and Anti-Helminth Immunity Laboratory, Mill Hill Laboratory, The Francis Crick Institute, London NW7 1AA, England, UK., Coomes SM; Allergy and Anti-Helminth Immunity Laboratory, Mill Hill Laboratory, The Francis Crick Institute, London NW7 1AA, England, UK., Kannan Y; Allergy and Anti-Helminth Immunity Laboratory, Mill Hill Laboratory, The Francis Crick Institute, London NW7 1AA, England, UK., Gialitakis M; Ahr Immunity Laboratory, Mill Hill Laboratory, The Francis Crick Institute, London NW7 1AA, England, UK., Entwistle LJ; Allergy and Anti-Helminth Immunity Laboratory, Mill Hill Laboratory, The Francis Crick Institute, London NW7 1AA, England, UK., Perez-Lloret J; Allergy and Anti-Helminth Immunity Laboratory, Mill Hill Laboratory, The Francis Crick Institute, London NW7 1AA, England, UK., Czieso S; Allergy and Anti-Helminth Immunity Laboratory, Mill Hill Laboratory, The Francis Crick Institute, London NW7 1AA, England, UK., Okoye IS; Allergy and Anti-Helminth Immunity Laboratory, Mill Hill Laboratory, The Francis Crick Institute, London NW7 1AA, England, UK., Rückerl D; Faculty of Life Sciences (3IR), University of Manchester, Manchester M13 9PT, England, UK., Allen JE; Faculty of Life Sciences (3IR), University of Manchester, Manchester M13 9PT, England, UK., Brombacher F; International Centre for Genetic Engineering and Biotechnology, University of Cape Town, Institute of Infectious Disease and Molecular Medicine and South African Medical Research Council, 7925 Cape Town, South Africa., Wilson MS; Allergy and Anti-Helminth Immunity Laboratory, Mill Hill Laboratory, The Francis Crick Institute, London NW7 1AA, England, UK wilson.mark@gene.com.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2017 Jun 05; Vol. 214 (6), pp. 1809-1826. Date of Electronic Publication: 2017 May 15.
Autor:
Kannan Y; Francis Crick Institute, Mill Hill Laboratory, the Ridgeway, London, United Kingdom., Li Y; Francis Crick Institute, Mill Hill Laboratory, the Ridgeway, London, United Kingdom., Coomes SM; Francis Crick Institute, Mill Hill Laboratory, the Ridgeway, London, United Kingdom., Okoye IS; Francis Crick Institute, Mill Hill Laboratory, the Ridgeway, London, United Kingdom., Pelly VS; Francis Crick Institute, Mill Hill Laboratory, the Ridgeway, London, United Kingdom., Sriskantharajah S; Francis Crick Institute, Mill Hill Laboratory, the Ridgeway, London, United Kingdom., Gückel E; Francis Crick Institute, Mill Hill Laboratory, the Ridgeway, London, United Kingdom., Webb L; Faculty of Life Sciences, Manchester Collaborative Centre for Inflammation Research, the University of Manchester, Manchester, United Kingdom., Czieso S; Francis Crick Institute, Mill Hill Laboratory, the Ridgeway, London, United Kingdom., Nikolov N; Francis Crick Institute, Mill Hill Laboratory, the Ridgeway, London, United Kingdom., MacDonald AS; Faculty of Life Sciences, Manchester Collaborative Centre for Inflammation Research, the University of Manchester, Manchester, United Kingdom., Ley SC; Francis Crick Institute, Mill Hill Laboratory, the Ridgeway, London, United Kingdom. Electronic address: Steve.Ley@crick.ac.uk., Wilson MS; Francis Crick Institute, Mill Hill Laboratory, the Ridgeway, London, United Kingdom. Electronic address: Mark.Wilson@crick.ac.uk.
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2017 Feb; Vol. 139 (2), pp. 655-666.e7. Date of Electronic Publication: 2016 Jul 05.